Claude A. Piché
Amministratore Delegato presso Locemia Solutions ULC
Profilo
Claude A.
Piché is the founder of Locemia Solutions ULC.
He is currently a Director at Zucara Therapeutics, Inc., Woolsey Pharmaceuticals, Inc., and Equinoxe Virtual Clinic Corp.
He also holds the position of VP-Clinical Development & Regulatory Affairs at PR Pharmaceuticals, Inc. since 2000.
Piché holds a doctorate degree from the University of Saskatchewan and a graduate degree from the University of Calgary.
Posizioni attive di Claude A. Piché
| Società | Posizione | Inizio |
|---|---|---|
PR Pharmaceuticals, Inc.
 PR Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PR Pharmaceuticals, Inc. develops, manufactures and commercialization of bioactive compounds in sustained-release formulations. It offers injectable and biodegradable formulations to treat chronic diseases. It produces drug delivery technologies for human and animal health. Its products include Insular, Pulmolar, and Somalar. The company was founded in 1998 by Steve R. Howe & William R. Lance and is located in Fort Collins, CO | Consigliere Generale | 01/05/2000 |
Locemia Solutions ULC
 Locemia Solutions ULC Pharmaceuticals: MajorHealth Technology Locemia Solutions ULC develops needle-free glucagon nasal powder for treating severe hypoglycemia. The company was founded by Claude Piche and Robert Oringer and is headquartered in Montréal, Canada. | Amministratore Delegato | - |
Woolsey Pharmaceuticals, Inc.
 Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | - |
Equinoxe Virtual Clinic Corp.
 Equinoxe Virtual Clinic Corp. Internet Software/ServicesTechnology Services Part of TELUS Corp., Equinoxe Virtual Clinic Corp. is a Canadian company that provides online access to family doctors, nurses and specialists through computer, tablet and smart phones. The company is based in Montréal, Canada. The company was founded in 1987 by Danielle Pollack. The CEO is Daniel Martz. Equinoxe Virtual Clinic was acquired by TELUS Corp. from 9422-3047 Quebec, Inc. on December 18, 2020. | Direttore/Membro del Consiglio | - |
Formazione di Claude A. Piché
| University of Saskatchewan | Doctorate Degree |
| University of Calgary | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
PR Pharmaceuticals, Inc.
PR Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PR Pharmaceuticals, Inc. develops, manufactures and commercialization of bioactive compounds in sustained-release formulations. It offers injectable and biodegradable formulations to treat chronic diseases. It produces drug delivery technologies for human and animal health. Its products include Insular, Pulmolar, and Somalar. The company was founded in 1998 by Steve R. Howe & William R. Lance and is located in Fort Collins, CO | Health Technology |
Locemia Solutions ULC
Locemia Solutions ULC Pharmaceuticals: MajorHealth Technology Locemia Solutions ULC develops needle-free glucagon nasal powder for treating severe hypoglycemia. The company was founded by Claude Piche and Robert Oringer and is headquartered in Montréal, Canada. | Health Technology |
Woolsey Pharmaceuticals, Inc.
Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Health Technology |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Health Technology |
Equinoxe Virtual Clinic Corp.
Equinoxe Virtual Clinic Corp. Internet Software/ServicesTechnology Services Part of TELUS Corp., Equinoxe Virtual Clinic Corp. is a Canadian company that provides online access to family doctors, nurses and specialists through computer, tablet and smart phones. The company is based in Montréal, Canada. The company was founded in 1987 by Danielle Pollack. The CEO is Daniel Martz. Equinoxe Virtual Clinic was acquired by TELUS Corp. from 9422-3047 Quebec, Inc. on December 18, 2020. | Technology Services |
- Borsa valori
- Insiders
- Claude A. Piché
